News Daily News Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All L.A. McKeown April 05, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News Experts Update Antithrombotic Advice in AF Patients Undergoing PCI Todd Neale February 09, 2021
News Daily News REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients Todd Neale January 13, 2021
News Daily News In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition Michael O'Riordan December 11, 2020
News Daily News Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD Michael O'Riordan December 07, 2020
News Conference News AHA 2020 Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT Shelley Wood November 15, 2020
News Conference News AHA 2020 Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT Todd Neale November 15, 2020
News Daily News Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5 Michael O'Riordan November 03, 2020
News Daily News Superiority of Ticagrelor Over Clopidogrel in ACS Questioned Todd Neale October 29, 2020
News Conference News TCT 2020 Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate Shelley Wood October 14, 2020
News Conference News ESC 2020 LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease Caitlin E. Cox August 31, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis Yael L. Maxwell June 30, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Daily News FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention Shelley Wood June 01, 2020
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020
News Daily News FOURIER Surveys Reassure About Cognitive Safety of Evolocumab Todd Neale May 06, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020